The HOXD9-mediated PAXIP1-AS1 regulates gastric cancer progression through PABPC1/PAK1 modulation

[1]  Haishan Huang,et al.  Lnc00892 competes with c-Jun to block NCL transcription, reducing the stability of RhoA/RhoC mRNA and impairing bladder cancer invasion , 2021, Oncogene.

[2]  Ran Ma,et al.  lncRNA THAP7-AS1, transcriptionally activated by SP1 and post-transcriptionally stabilized by METTL3-mediated m6A modification, exerts oncogenic properties by improving CUL4B entry into the nucleus , 2021, Cell Death & Differentiation.

[3]  J. Ouyang,et al.  The prognostic impacts of PABPC1 expression on gastric cancer patients. , 2021, Future oncology.

[4]  Sanjeev Das,et al.  The lncRNA HMS recruits RNA-binding protein HuR to stabilize the 3′-UTR of HOXC10 mRNA , 2021, The Journal of biological chemistry.

[5]  Rong Song,et al.  LncRNA PAXIP1‐AS1 fosters the pathogenesis of pulmonary arterial hypertension via ETS1/WIPF1/RhoA axis , 2021, Journal of cellular and molecular medicine.

[6]  Wei Zheng,et al.  H3K27ac-induced lncRNA PAXIP1-AS1 promotes cell proliferation, migration, EMT and apoptosis in ovarian cancer by targeting miR-6744-5p/PCBP2 axis , 2021, Journal of Ovarian Research.

[7]  Liang Chen,et al.  LncRNA PCBP1-AS1 correlated with the functional states of cancer cells and inhibited lung adenocarcinoma metastasis by suppressing the EMT progression. , 2021, Carcinogenesis.

[8]  B. Séraphin,et al.  A conserved motif in human BTG1 and BTG2 proteins mediates interaction with the poly(A) binding protein PABPC1 to stimulate mRNA deadenylation , 2021, RNA biology.

[9]  F. Fu,et al.  LncRNA PCIR Is an Oncogenic Driver via Strengthen the Binding of TAB3 and PABPC4 in Triple Negative Breast Cancer , 2021, Frontiers in Oncology.

[10]  Y. Liao,et al.  Long noncoding RNA (lncRNA) EIF3J-DT induces chemoresistance of gastric cancer via autophagy activation , 2021, Autophagy.

[11]  Xiaoxu Tian,et al.  MKRN3-mediated ubiquitination of Poly(A)-binding proteins modulates the stability and translation of GNRH1 mRNA in mammalian puberty , 2021, Nucleic acids research.

[12]  Yufeng Yuan,et al.  A novel long non-coding RNA RP11-286H15.1 represses hepatocellular carcinoma progression by promoting ubiquitination of PABPC4. , 2020, Cancer letters.

[13]  Z. YuFeng,et al.  Expression and prognostic roles of PABPC1 in hepatocellular carcinoma. , 2020, International journal of surgery.

[14]  K. Hu,et al.  LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network , 2020, Theranostics.

[15]  Lingjuan Zhu,et al.  Long non-coding RNAs in gastric cancer: New emerging biological functions and therapeutic implications , 2020, Theranostics.

[16]  Jincai Wang,et al.  RETRACTED ARTICLE: STAT1-induced upregulation of lncRNA LINC01123 predicts poor prognosis and promotes the progression of endometrial cancer through miR-516b/KIF4A , 2020, Cell cycle.

[17]  K. Miyazono,et al.  TNF‐α enhances TGF‐β‐induced endothelial‐to‐mesenchymal transition via TGF‐β signal augmentation , 2020, Cancer science.

[18]  Wenjing Zhang,et al.  HOXD9 promote epithelial‐mesenchymal transition and metastasis in colorectal carcinoma , 2020, Cancer medicine.

[19]  Hui Wang,et al.  MiR‐210‐3p‐EphrinA3‐PI3K/AKT axis regulates the progression of oral cancer , 2020, Journal of cellular and molecular medicine.

[20]  Zhiguo Li,et al.  11 Long noncoding RNA UCA1 functions as miR‐135a sponge to promote the epithelial to mesenchymal transition in glioma , 2020, Journal of cellular biochemistry.

[21]  Jian Zheng,et al.  PABPC1-induced stabilization of BDNF-AS inhibits malignant progression of glioblastoma cells through STAU1-mediated decay , 2020, Cell Death & Disease.

[22]  Hong Jiang,et al.  Long non-coding RNA PAXIP1-AS1 facilitates cell invasion and angiogenesis of glioma by recruiting transcription factor ETS1 to upregulate KIF14 expression , 2019, Journal of Experimental & Clinical Cancer Research.

[23]  Wenjing Zhang,et al.  HOXD9 promotes the growth, invasion and metastasis of gastric cancer cells by transcriptional activation of RUFY3 , 2019, Journal of Experimental & Clinical Cancer Research.

[24]  Yun Cui,et al.  LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc , 2019, Nature Communications.

[25]  Dandan Song,et al.  Crosstalk between the lncRNA UCA1 and microRNAs in cancer , 2019, FEBS letters.

[26]  Mengqing Li,et al.  LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway , 2019, Theranostics.

[27]  J. Machlowska,et al.  The Pattern of Signatures in Gastric Cancer Prognosis , 2018, International journal of molecular sciences.

[28]  K. Dhama,et al.  The relevance of gastric cancer biomarkers in prognosis and pre- and post- chemotherapy in clinical practice. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[29]  Yang Cao,et al.  LncRNA‐PAGBC acts as a microRNA sponge and promotes gallbladder tumorigenesis , 2017, EMBO reports.

[30]  Ning-Bo Hao,et al.  The role of miRNA and lncRNA in gastric cancer , 2017, Oncotarget.

[31]  Q. Liao,et al.  Overexpression of PAK1 Correlates with Aberrant Expression of EMT Markers and Poor Prognosis in Non-Small Cell Lung Cancer , 2017, Journal of Cancer.

[32]  Jide Wang,et al.  Rufy3 promotes metastasis through epithelial-mesenchymal transition in colorectal cancer. , 2017, Cancer letters.

[33]  Zhenyu Xu,et al.  Collapsin response mediator protein-1 (CRMP1) acts as an invasion and metastasis suppressor of prostate cancer via its suppression of epithelial–mesenchymal transition and remodeling of actin cytoskeleton organization , 2016, Oncogene.

[34]  Lei Dong,et al.  HOXD9 promotes epithelial–mesenchymal transition and cancer metastasis by ZEB1 regulation in hepatocellular carcinoma , 2015, Journal of experimental & clinical cancer research : CR.

[35]  G. Jeschke,et al.  AUF-1 and YB-1 independently regulate β-globin mRNA in developing erythroid cells through interactions with poly(A)-binding protein , 2015, Mechanisms of Development.

[36]  Jing Luo,et al.  Clinicopathological and cellular signature of PAK1 in human bladder cancer , 2015, Tumor Biology.

[37]  J. Li,et al.  PAK1 regulates RUFY3-mediated gastric cancer cell migration and invasion , 2015, Cell Death and Disease.

[38]  Liwei Xie,et al.  The long intergenic noncoding RNA UFC1, a target of MicroRNA 34a, interacts with the mRNA stabilizing protein HuR to increase levels of β-catenin in HCC cells. , 2015, Gastroenterology.

[39]  R. Neve,et al.  PAK1 mediates pancreatic cancer cell migration and resistance to MET inhibition , 2014, Journal of Pathology.

[40]  H. Okano,et al.  Functional analysis of HOXD9 in human gliomas and glioma cancer stem cells , 2011, Molecular Cancer.

[41]  J. Bähler,et al.  The nuclear poly(A)-binding protein interacts with the exosome to promote synthesis of noncoding small nucleolar RNAs. , 2010, Molecular cell.

[42]  Gerhard Christofori,et al.  EMT, the cytoskeleton, and cancer cell invasion , 2009, Cancer and Metastasis Reviews.

[43]  K. Imakawa,et al.  Stability of casein mRNA is ensured by structural interactions between the 3'-untranslated region and poly(A) tail via the HuR and poly(A)-binding protein complex. , 2006, Biochimica et biophysica acta.

[44]  P. Guzmán,et al.  Four distinct classes of proteins as interaction partners of the PABC domain of Arabidopsis thaliana Poly(A)-binding proteins , 2005, Molecular Genetics and Genomics.